Description
Ebixa (memantine hydrochloride) is a prescription medication used in the management of moderate to severe Alzheimer’s disease. By targeting certain chemicals in the brain associated with memory and learning, Ebixa helps to slow cognitive decline and improve daily functioning. While it’s not a cure for Alzheimer’s, Ebixa plays a valuable role in enhancing the quality of life for patients, assisting with memory, attention, and language skills.
Ebixa belongs to a class of drugs known as NMDA (N-methyl-D-aspartate) receptor antagonists. It works by modulating the effects of glutamate, a neurotransmitter involved in learning and memory that can become overactive in Alzheimer’s patients, leading to cell damage. By regulating this activity, Ebixa supports cognitive functions and helps manage symptoms of dementia.